Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Biomaterials. 2014 Mar 25;35(18):4863–4877. doi: 10.1016/j.biomaterials.2014.02.054

Table 2.

Percentage decrease in viability assessed by Alamar Blue assay of adMSCs and bmMSCs treated with GNOs, GONRs and GONPs at concentration of 300 μg/ml at day 1 and 3 compared to control.


adMSC bmMSC

Day 1 Day 3 Day 1 Day 3
GNOs 86% 69% 50% 39%
GONRs 93% 79% 67% 72%
GONPs 100% 98% 62% 93%